-+ 0.00%
-+ 0.00%
-+ 0.00%

Mizuho Maintains Outperform on Chemours, Lowers Price Target to $25

Benzinga·07/01/2026 11:41:36
Listen to the news
Mizuho analyst John Roberts maintains Chemours (NYSE:CC) with a Outperform and lowers the price target from $30 to $25.